| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $282.9M | — | -20.6% |
| Cost of Revenue | $182.5M | — | -2.8% |
| Gross Profit | $100.4M | — | -40.3% |
| R&D Expense | $44.9M | — | -10.6% |
| SG&A Expense | $33.3M | — | -2.3% |
| Operating Income | -$29.6M | — | -192.9% |
| Pre-tax Income | -$13.9M | — | -129.6% |
| Income Tax | -$6.5M | — | -137.6% |
| Net Income | -$7.4M | — | -124.9% |
| EPS (Basic) | -$0.06 | — | -126.1% |
| EPS (Diluted) | -$0.06 | — | -127.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $497.5M | +4.9% | +42.1% |
| Short-term Investments | $433.1M | -58.3% | -61.2% |
| Accounts Receivable | $196.6M | -14.5% | -12.9% |
| Inventory | $290.7M | +0.9% | +101.8% |
| Current Assets | $1.83B | -29.8% | -16.7% |
| Total Assets | $2.72B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $102.9M | — | +112.5% |
| Capital Expenditures | $19.9M | — | +36.2% |
| Investing Cash Flow | $576.4M | — | +409.8% |
| Financing Cash Flow | -$651.2M | — | -204.0% |
| Free Cash Flow | $83.0M | — | +145.4% |
| -12.3% |
| Current Liabilities | $481.8M | -61.8% | -58.4% |
| Long-term Debt | $572.5M | -52.5% | -52.4% |
| Total Liabilities | $1.62B | -33.1% | -29.4% |
| Stockholders' Equity | $1.10B | +1.4% | +36.0% |